abstract |
The present invention relates to a novel compound according to the following formula (1) that plays a role in a sphingosine-1-phosphate receptor agonist useful in the treatment of autoimmune disorders, a method for producing the same, a pharmaceutical composition containing them as an active ingredient, and It relates to the use. (1) (Wherein R1, R2, X, W, Q and S have the same meanings as defined in the specification.) |